A Phase 2 Study to Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic Dermatitis
Clinical trial NCT07175233 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07175233
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-27
- Primary completion
- 2026-08-15
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.